Loading...
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
The standard dosing of the Pfizer/BioNTech BNT162b2 mRNA vaccine validated in clinical trials includes two doses administered three weeks apart. While the decision by some public health authorities to space the doses because of limiting supply has raised concerns about vaccine efficacy, data indicat...
Na minha lista:
| Udgivet i: | bioRxiv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cold Spring Harbor Laboratory
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7987016/ https://ncbi.nlm.nih.gov/pubmed/33758857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.03.18.435972 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|